Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001213900-26-008173
Filing Date
2026-01-27
Accepted
2026-01-27 15:04:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 FOR REGISTRATION OF CERTAIN CLASSES ea0274301-8a12b_polaryx.htm 8-A12B 20344
  Complete submission text file 0001213900-26-008173.txt   21407
Mailing Address SOUTH TOWER, 140 E RIDGEWOOD AVENUE SUITE 415 PARAMUS NJ 07652
Business Address 140 EAST RIDGEWOOD AVENUE SUITE 415, SOUTH TOWER PARAMUS NJ 07652 201-940-7236
Polaryx Therapeutics, Inc. (Filer) CIK: 0002075320 (see all company filings)

EIN.: 000000000 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-43080 | Film No.: 26564500
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)